Goto, G.H. Katayama, H. Tanigaki, Y. Fushiki, S. Nishizawa, Y and Nishizawa, Y.
(2008) Methylcobalamin inhibits fibroblast growth factor-8 stimulated proliferation
and induces apoptosis in Shionogi carcinoma cells. Int. J. Vitam. Nutr. Res., 78, 21-26
Kataoka, T. Tsukamoto, Y. Matsumura, M. Miyake, A. Kamiura, S. Ishiguro, S. and
Nishizawa, Y. (2008) Expression of p21Cip1/Waf1 and p27Kip1 in small cell
neuroendocrine carcinoma of the uterine cervix. Int. J. Surg. Pathol., 16, 11-15
Baba, M. Inoue, M. Itoh, K. Nishizawa, Y. (2008) Blocking CD147 induces cell death
in cancer cells through impairment of glycolytic energy metabolism. Biochem.
Kataoka, TR. Ioka, T. Tsukamoto, Y. Matsumura, M. Ishiguro, S. Nishizawa, Y. (2007)
Nuclear expression of STAT5 in intraductal papillary mucinous neoplasms of the
pancreas. Int. J. Surg. Pathol., 15, 277-281
Nishizawa, Y., Yamasaki, M., Katayama, H., Amakata, Y., Fushiki, S. and Nishizawa,
Y. (2007) Establishment of progesterone-sensitive cell line from human lung cancer.
Goto, H. G., Nishizawa, Y., Katayama, H., Murashima, T., Yamasaki, M., Tanigaki, Y.,
Kimura, S., Fushiki, S. and Nishizawa, Y. (2007) Induction of apoptosis in an
estrogen-responsive mouse Leydig tumor cell by leukotriene. Oncol. Rep., 17,
Nakamura, Y., Yamada, N., Ohyama, H., Nakasho, K., Nishizawa, Y., Okamoto, T.,
Futani, H., Yoshiya, S., Okamura, H. and Terada, N. (2006) Effect of interleukin-18 on
metastasis of mouse osteosarcoma cells. Cancer Immunol. Immunother., 55,
Hamanaka, Y., Mukai, M., Shimamura, M., Kitagawa, T., Nishida, T., Isohashi, H., Ito,
T., Nishizawa, Y., Tatsuta, M., Matsuda, H. and Inoue, M. (2005) Suppression of
P13K/mTOR pathway rescues LLC cells from cell death induced by hypoxia.
Biochem. Biophys. Res. Commun., 29, 318-326.
Baba M, Itoh K, Tatsuta M. (2004) Glycine-extended gastrin induces
matrixmetalloproteinase-1- and -3-mediated invasion of human colon cancer cells
through type I collagen gel and Matrigel. Int. J. Cancer, 111, 23-31.
10. Okamoto, T., Yamada, N., Tsujimura, T., Sugihara, A., Nishizawa, Y., Ueda, H.,
Kashiwamura, S.-i., Tsutsui, H., Futani, H., Maruo, S., Okamura, H. and Terada, N.
(2004) Inhibition by interleukin-18 of the growth of Dunn osteosarcoma cells. J.
Interferon & Cytokine Res., 24, 161-167.
11. Nishizawa, Y., Nishizawa, Y., Goto, G.H., Tanigaki, Y., Nosaka, S., Yoshioka, F.,
Amenomori, Y., Azuchi, K., Amakata, Y., Nagano, F., Yamada, M., Yasuda, R.,
Kawata, Y., Hirata, Y. and Fushiki, S. (2003) Health hazards and biological effects of
welding fumes on thyroid function in welders compared with non-welding
healthy-subjects who showed no statistical significance in geographic characteristics.
12. Yamamoto, T., Nishiguchi, M., Inoue, N., Goto, G.H., Kudawara, I., Ueda, T.,
Yoshikawa, H., Tanigaki, Y. and Nishizawa, Y. (2002) Inhibition of murine
osteosarcoma cell proliferation by glucocorticoid. Anticancer Res., 22, 4151-4156.
13. Nishizawa, Y., Goto, G.H., Tanigaki, Y., Fushiki, S. and Nishizawa, Y. (2001)
Induction of apoptosis in an androgen-dependent mouse mammary carcinoma cell line
by methylcobalamin. Anticancer Res., 21, 1107-1110.
14. Kudawara, I., Ueda, T., Yoshikawa, H., Miyama, Y., Yamamoto, T. and Nishizawa, Y.
(2001) In vivo inhibition of tumour growth by dexamethasone in murine
osteosarcomas. European J. Cancer, 37, 1703-1708.
15. Takakura, A., Miyoshi, J., Ishizaki, H., Tanaka, M., Togawa, A., Nishizawa, Y.,
Yoshida, H., Nishikawa, S. and Takai, Y. (2000) Involvement of a small GTP-binding
protein (G protein) regulator, small G protein GDP dissociation stimulator, in
antiapoptotic cell survival signaling. Mol. Biol. Cell, 11, 1875-1856.
16. Yamamoto, T., Nishizawa, Y., Tsuji, M., Saitoh, Y., Funai, H., Hirai, T., Sugihara, A.,
Tsujimura, T., Nakata, Y., Ishiguro, S. and Terada, N. (1999) Expression of vascular
endothelial growth factor in normal pituitary cells and pituitary adenomas producing
adrenocorticotropic hormone. Endocrine Pathology, 10, 157-164.
17. Nishizawa, Y., Yamamoto, T., Tanigaki, Y., Kasugai, T., Mano, M., Ishiguro, S.,
Fushiki, S., Poirier, L.A. and Nishizawa, Y. (1999) Methylcobalamin decreases mRNA
levels of androgen-induced growth factor in androgen-dependent Shionogi carcinoma
115 cells. Nutrition and Cancer, 35, 195-201.
18. Yamamoto, T., Terada, N., Seiyama, A., Nishizawa, Y., Akedo, H. and Kosaka, H.
(1998) Increase in experimental pulmonary metastasis in mice by L-arginine under
inhibition of nitric oxide production by NG-nitro-L-arginine methyl ester. Int. J.
19. Nishizawa, Y., Yamamoto, T., Terada, N., Fushiki, S., Matsumoto, K. and Nishizawa,
Y. (1997) Effects of methylcobalamin on the proliferation of androgen-sensitive or
estrogen-sensitive malignant cells in culture and in vivo. Int. J. Vitam. Nutr. Res., 67,
20. Nishizawa, Y., Yamamoto, T., Terada, N., Fushiki, S., Amakata, Y. and Nishizawa, Y.
(1996) Effects of antiallergic drugs on the proliferation of estrogen-sensitive mouse
Leydig cell line. Anticancer Res., 16, 1241-1246.
21. Yamanishi, H., Tanaka, A., Miyamoto, K., Takeda, M., Nishizawa, Y., Koga, M.,
Miyata, M. and Matsumoto, K. (1995) An essential role of androgen-induced growth
factor in glucocorticoid-dependent autocrine loop in Shionogi carcinoma 115 cells. J.
Steroid Biochem. Molec. Biol., 52, 49-53.
22. Nishizawa, Y., Yamamoto, T., Terada, N., Sato, B., Matsumoto, K. and Nishizawa, Y.
(1995) Inhibition of the proliferation of androgen-dependent SC-3 cells by
methylcobalamin. Oncology Reports, 2, 129-132.
23. Yamamoto, T., Nishizawa, Y., Uchida, N., Terada, N. and Petrow, V. (1994) Effects of
megestrol acetate and 1-dehydromegestrol acetate on in vitro and in vivo growth of
androgen-responsive Shionogi mouse mammary carcinoma cells. Oncol. (Life Sci.
24. Nishizawa, Y., Nishizawa, Y., Yamamoto, T., Terada, N., Amakata, Y., Matsumoto, K.
and Sato, B. (1994) Progression of mouse transformed Leydig cells from
estrogen-sensitive to estrogen-insensitive growth phenotype concomitant with loss of
leukotriene D4 receptor. Internat. J. Oncology, 5, 1077-1084.
25. Kondoh, G., Nishimune, Y., Nishizawa, Y., Hayasaka, N., Matsumoto, K. and Hakura,
A. (1994) Establishment and further characterization of a line of transgenic mice
showing testicular tumorigenesis at 100% incidence. J. Urology, 152, 2151-2154.
26. Yamamoto, T., Li, I., Uchida, N., Nishizawa, Y., Yamamoto, R., Terada, N., Taniguchi,
H., Matsumoto, K. and Sato, B. (1992) Stimulation by estrogen and progesterone of
the in vivo growth of transformed murine Leydig cells only at the limited early phase
of growth. Anticancer Res., 12, 1339-1346.
27. Sato, B., Hirose, T., Kasayama, S., Takabayashi, H., Koga, M. and Nishizawa, Y.
(1992) Transformed murine Leydig cells in serum-free culture: useful model for
analysis of steroid hormone-induced cell growth and cell morphology (Review). Int. J.
28. Nishii, K., Nishizawa, Y., Nishizawa, Y., Matsumoto, K. and Sato, B. (1991) Inhibition
of murine transformed Leydig cell proliferation by leukotrienes in serum-free culture.
29. Lu, J., Matsumoto, K., Nishizawa, Y., Tanaka, A., Hirose, T. and Sato, B. (1991)
Non-classical androgenic actions of RU38486 in androgen-responsive Shionogi
carcinoma 115 cells in serum-free culture. J. Steroid Biochem. Molec. Biol., 39,
30. Nishizawa, Y., Nishii, K., Nishizawa, Y., Koga, M., Kishimoto, S., Matsumoto, K. and
Sato, B. (1990) Effects of estrogen on cell proliferation and leukotriene formation in
transformed mouse Leydig cells cultured under serum-free conditions. Cancer Res., 50,
31. Nishizawa, Y., Nishii, K., Kishimoto, S., Matsumoto, K. and Sato, B. (1990)
Regulatory role of arachidonic acid-derived matabolites for proliferation of
transformed murine Leydig cell in serum-free culture condition. Anticancer Res., 10,
32. Nishizawa, Y., Sato, B., Nishii, K., Kishimoto, S. and Matsumoto, K. (1989) Effect of
androgen on proliferation of estrogen-responsive transformed mouse Leydig cells in
serum-free culture. Cancer Res., 49, 1377-1382.
33. Nishizawa, Y., Sato, B., Miyashita, Y., Tsukada, S., Hirose, T., Kishimoto, S. and
Matsumoto, K. (1988) Autocrine regulation of cell proliferation by estradiol and
hydroxytamoxifen of transformed mouse Leydig cells in serum-free culture.
34. Nakamura, N., Nishizawa, Y., Noguchi, S., Uchida, N., Sato, B. and Matsumoto, K.
(1987) Action mechanisms of physiological doses of androgen or pharmacological
doses of estrogen in growth stimulation of Shionogi carcinoma 115 in mice. J. Steroid
35. Hiraoka, D., Nakamura, N., Nishizawa, Y., Uchida, N., Noguchi, S., Matsumoto, K.
and Sato, B. (1987) Inhibitory and stimulatory effects of glucocorticoid on
androgen-induced growth of murine Shionogi carcinoma 115 in vivo and in cell
36. Nishizawa, Y., Maeda, Y., Noma, K., Sato, B., Matsumoto, K. and Yamamura, Y.
(1981) A modulator which converts activated estrogen receptor to a biologically
inactive aggregated form. Endocrinology, 109, 1463-1472.
Basic Information and A Feminist Perspective W hat is Implanon®? Implanon ® is a long-acting hormonal contraceptive implant in the form of a rod measuring 34 mm long and 2.4 mm in diameter that prevents pregnancy for a period of three years. Implanon ® is inserted under the skin of a woman’s upper arm. It prevents pregnancy by gradually dispensing etonogestrel, a proges
NITEC PHARMA GRANTS EXCLUSIVE EUROPEAN DISTRIBUTION LICENCE TO MUNDIPHARMA FOR LODOTRATM Basel/Reinach, Switzerland, 31 March 2009 – Nitec Pharma AG (“Nitec” or “Nitec Pharma”) , a Switzerland-based specialty pharma company focused on the development and commercialization of medicines to treat chronic inflammation and pain-related diseases, today announced that it has